No Data
No Data
SLB, First Solar And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed slightly lower on Wednesday. Investors, meanwhile, focused on some notable insider trades.When insiders sell shares, it could be a preplanned sale, or could indicate their concer
Walmart, Vertex Pharmaceuticals And More On CNBC's 'Final Trades'
Joseph M. Terranova of Virtus Investment Partners named VanEck Semiconductor ETF (NASDAQ:SMH) on CNBC's "Halftime Report Final Trades." If NVIDIA Corporation (NASDAQ:NVDA) goes above the $1,000 level,
Insider Sale: CEO & President Reshma Kewalramani Sells 15,202 Shares of Vertex ...
On May 20, 2024, Reshma Kewalramani, CEO & President of Vertex Pharmaceuticals Inc (NASDAQ:VRTX), executed a sale of 15,202 shares of the company, according to the SEC Filing.
Vertex Pharmaceuticals(VRTX.US) Officer Sells US$6.8 Million in Common Stock
$Vertex Pharmaceuticals(VRTX.US)$ Officer Kewalramani Reshma sold 15,202 shares of common stock on May 20, 2024 at an average price of $447 for a total value of $6.8 million.Source: Announcement What
Vertex Pharmaceuticals Insider Sold Shares Worth $6,795,294, According to a Recent SEC Filing
Reshma Kewalramani, Director, CEO & President, on May 20, 2024, sold 15,202 shares in Vertex Pharmaceuticals (VRTX) for $6,795,294.
Vertex to Participate in Upcoming June Investor Conferences
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) today announced management participation in two upcoming investor conferences. Dr. Reshma Kewalramani, Chief Executive Officer and President, will present at the
No Data